Ambagon Therapeutics is a series a startup. 1 investor tracked. Status: possibledead.
Based in the Netherlands, Ambagon Therapeutics is a startup. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Ambagon Therapeutics is a biopharmaceutical company discovering and developing novel therapeutics that unlock intrinsically disordered proteins (IDPs) as drug targets.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.